RHOB and neoplasm: Additionally, we show that the ROCK inhibitor RKI-1447 suppresses ROCK-dependent signaling, tumorigenicity, and invasion by affecting RHOA, RHOB, vimentin, and JUN in vitro and inhibits tumor growth in vivo.